Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

BACKGROUND: To investigate the efficacy of secukinumab in patients with active non-radiographic axial spondyloarthritis (nr-axSpA) grouped by disease activity as assessed by C-reactive protein (CRP) levels and/or magnetic resonance imaging (MRI) scores, human leukocyte antigen (HLA)-B27 status, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Jürgen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S., van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S., Porter, Brian O., Shete, Abhijit, Richards, Hanno B., Haemmerle, Sibylle, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418044/
https://www.ncbi.nlm.nih.gov/pubmed/34481517
http://dx.doi.org/10.1186/s13075-021-02613-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418044/
https://www.ncbi.nlm.nih.gov/pubmed/34481517
http://dx.doi.org/10.1186/s13075-021-02613-9

Ejemplares similares